Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

41.72
Delayed Data
As of Aug 22
 +0.30 / +0.72%
Today’s Change
32.76
Today|||52-Week Range
43.74
+3.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues938.5M910.4M910.5M886.1M
 
 
 
 
 
Cost of Goods Sold395.4M389.9M404.2M401.4M
 
 
 
 
 
Depreciation And Amortization81.7M86.1M89.9M89.7M
 
 
 
 
 
 
Operating ExpensesGross Income461.4M434.4M416.4M395.0M
 
 
 
 
 
General Expenses324.0M321.7M319.9M299.7M
 
 
 
 
 
Research And Development50.6M54.2M45.0M37.6M
 
 
 
 
 
Total Operating Expenses801.1M797.6M814.0M790.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income137.4M112.8M96.5M95.3M
 
 
 
 
 
Extraordinary Credit--2.9M4.7M857.0K
 
 
 
 
Extraordinary Charge-90.1M-72.2M-143.6M-109.4M
 
 
 
 
 
Interest Expense On Debt9.3M8.7M8.5M9.0M
 
 
 
 
 
Other Expenses-2.0M-3.8M-2.6M-5.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income36.4M31.2M-53.4M-27.5M
 
 
 
 
 
Income Taxes-1.3M-14.3M-2.2M-1.2M
 
 
 
 
 
Net Income35.1M16.9M-55.6M-26.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.6M51.5M50.9M51.5M
 
 
 
 
 
Shares To Calculate EPS Diluted52.4M52.1M50.9M51.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.67$0.32-$1.09-$0.51
 
 
 
 
 
EPS Diluted$0.67$0.32-$1.09-$0.51